Atlas Trials

MR-guided Adaptive Radiotherapy Combined With PD-1 Antibody and CAPOX for Locally Advanced Rectal Cancer

Clinical trial NCT06840665 · RECRUITING

Trial details

NCT number
NCT06840665
Sponsor
Fudan University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Locally Advanced Rectal Cancer
Start date
2024-08-13
Primary completion
2026-08-12
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.